CELUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Celularity Inc
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Oct 20, 2026
$1.16−0.09 (-7.20%)
Close on Oct 19, 2026
- Market cap
- $35.15M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
6.8%
2M of 32M shares
Institutional holders
39
5 new, 4 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Philip & Daniele Barach Family Trust | 5,514,686 | 15.80% | 13D (active) amendment | Jun 19, 2026 |
| Philp & Daniele Barach Family Trust | 3,012,048 | 9.56% | 13D (active) | Dec 19, 2025 |
| Lim Kok Thay | 14,138,161 | 41.00% | 13D (active) amendment | Jul 24, 2025 |
| Daniele Barach | 11,940,187 | 29.00% | 13D (active) amendment | Sep 23, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CELU | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| C V Starr & Co Inc | 764,069 | 2.35% | $1.58M | – | 0.84% |
| Vanguard Capital Management LLC | 621,105 | 1.91% | $371.42K | – | 0.00% |
| Geode Capital Management, LLC | 167,150 | 0.52% | $99.96K | −23,926 | 0.00% |
| Citadel Advisors LLC | 99,054 | 0.31% | $59.22K | New | 0.00% |
| Vanguard Fiduciary Trust Co | 79,874 | 0.25% | $47.77K | – | 0.00% |
| BlackRock, Inc. | 76,359 | 0.24% | $45.66K | −51,142 | 0.00% |
| State Street Corp | 57,830 | 0.18% | $34.58K | – | 0.00% |
| Hrt Financial LP | 56,591 | 0.17% | $33 | +43,807 | 0.00% |
| Northern Trust Corp | 44,163 | 0.14% | $26.41K | – | 0.00% |
| Biltmore Family Office, LLC | 35,000 | 0.11% | $20.93K | – | 0.00% |
| HB Wealth Management, LLC | 31,915 | 0.10% | $19.08K | −8,500 | 0.00% |
| Keynote Financial Services LLC | 29,920 | 0.09% | $17.89K | +600 | 0.01% |
| Jane Street Group, LLC | 28,713 | 0.09% | $17.17K | New | 0.00% |
| CenterStar Asset Management, LLC | 21,000 | 0.06% | $12.89K | +3,150 | 0.00% |
| Virtu Financial LLC | 18,697 | 0.06% | $11 | New | 0.00% |
| Royal Bank of Canada | 18,000 | 0.06% | $11.00K | – | 0.00% |
| IPG Investment Advisors LLC | 17,169 | 0.05% | $10.27K | – | 0.00% |
| IFP Advisors, Inc | 12,000 | 0.04% | $7.18K | +4,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 5,111 | 0.02% | $3.06K | +1,847 | 0.00% |
| Group One Trading, L.P. | 3,595 | 0.01% | $2.15K | +3,500 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 39 | 2M | 6.8% | 5 / 9 | 4 / 4 | 0M | 0M |
| Q1 2026 | 38 | 2M | 6.7% | 10 / 4 | 5 / 6 | 1M | 0M |
| Q4 2025 | 36 | 2M | 6.8% | 4 / 7 | 7 / 6 | 0M | 0M |
| Q3 2025 | 38 | 2M | 7.1% | 8 / 9 | 8 / 4 | 0M | 0M |
| Q2 2025 | 34 | 2M | 6.8% | 7 / 8 | 8 / 2 | 0M | 0M |
| Q1 2025 | 29 | 2M | 6.1% | 4 / 8 | 3 / 5 | 0M | 0M |
| Q4 2024 | 32 | 2M | 5.7% | 8 / 4 | 7 / 3 | 1M | 0M |
| Q3 2024 | 27 | 1M | 3.0% | 4 / 3 | 6 / 2 | 0M | 0M |
| Q2 2024 | 26 | 1M | 2.9% | 0 / 7 | 8 / 4 | 0M | 0M |
| Q1 2024 | 30 | 1M | 2.6% | 30 / 0 | 0 / 0 | 1M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of CELU | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 455,049 | 1.40% | $272.07K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 166,056 | 0.51% | $99.28K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 104,816 | 0.32% | $105.86K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 21,176 | 0.07% | $21.39K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 20,677 | 0.06% | $20.88K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 8,438 | 0.03% | $8.52K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Robert J. Hariri | Chief Executive Officer, Director | 2,853,553 | 8.79% | Apr 15, 2026 |
| Stephen Brigido | Pres., Functional Regeneration | 9,742 | 0.03% | Apr 15, 2026 |
| John R. Haines | Senior Exec Vice President | 30,179 | 0.09% | Apr 15, 2026 |
| Joseph DosSantos | Interim CFO | – | – | Jul 16, 2025 |
| David C. Beers | Chief Financial Officer | 18,201 | 0.06% | Apr 15, 2025 |
| Philip Alan Barach | Director, 10% owner | – | – | Sep 25, 2026 |
| Geoffrey M.D. Ling | Director | 256,026 | 0.79% | Jan 15, 2026 |
| Diane L. Parks | Director | 520,021 | 1.60% | Jan 15, 2026 |
| Peter Diamandis | Director | 394,150 | 1.21% | Jan 15, 2026 |
| Vincent LeVien | Director | 153,847 | 0.47% | Jan 15, 2026 |
| Dean C. Kehler | Director | 797,858 | 2.46% | Jan 6, 2025 |
| Richard J. Berman | Director | 67,416 | 0.21% | Jan 6, 2025 |
| Daniele Wolf Barach | 10% owner | – | – | Sep 25, 2026 |
| & Daniele Barach Family Trust Philip | 10% owner | – | – | Sep 25, 2026 |
| Berhad Genting | 10% owner | 6,338,161 | 19.53% | Jul 28, 2025 |
| World Inc Pte. Ltd. Resorts | 10% owner | – | – | Jul 28, 2025 |
| Kok Thay Lim | 10% owner | 30,288,000 | 93.34% | Jul 28, 2025 |
| Ltd Dragasac | 10% owner | 30,062,778 | 92.64% | Jan 28, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| John R. Haines Senior Exec Vice President | Apr 13, 2026 | Tax withholding | −583 | $1.28 | $746 | 30,179 |
| John R. Haines Senior Exec Vice President | Apr 13, 2026 | Option exercise | +1,641 | – | – | 30,762 |
| Stephen Brigido Pres., Functional Regeneration | Apr 13, 2026 | Option exercise | +821 | – | – | 9,742 |
| Stephen Brigido Pres., Functional Regeneration | Apr 13, 2026 | Tax withholding | −268 | $1.28 | $343 | 9,474 |
| Robert J. Hariri Chief Executive Officer, Director | Apr 13, 2026 | Tax withholding | −1,182 | $1.28 | $1.51K | 2,853,553 |
| Robert J. Hariri Chief Executive Officer, Director | Apr 13, 2026 | Option exercise | +3,281 | – | – | 2,854,735 |
| Peter Diamandis Director | Jan 12, 2026 | Award | +20,385 | – | – | 394,150 |
| Diane L. Parks Director | Jan 12, 2026 | Award | +30,000 | – | – | 520,021 |
| Geoffrey M.D. Ling Director | Jan 12, 2026 | Award | +19,231 | – | – | 256,026 |
| Vincent LeVien Director | Jan 12, 2026 | Award | +28,847 | – | – | 153,847 |
| Geoffrey M.D. Ling Director | Jan 12, 2026 | Award | +19,231 | – | – | 256,026 |
| Peter Diamandis Director | Jan 12, 2026 | Award | +20,385 | – | – | 394,150 |
| Vincent LeVien Director | Jan 12, 2026 | Award | +28,847 | – | – | 153,847 |
| Diane L. Parks Director | Jan 12, 2026 | Award | +30,000 | – | – | 520,021 |
| Peter Diamandis Director | Dec 29, 2025 | Award | +125,000 | – | – | 373,765 |
| Diane L. Parks Director | Dec 29, 2025 | Award | +125,000 | – | – | 490,021 |
| Vincent LeVien Director | Dec 29, 2025 | Award | +125,000 | – | – | 125,000 |
| Geoffrey M.D. Ling Director | Dec 29, 2025 | Award | +125,000 | – | – | 236,795 |
| Peter Diamandis Director | Dec 19, 2025 | Award | +67,416 | – | – | 248,765 |
| Diane L. Parks Director | Dec 19, 2025 | Award | +67,416 | – | – | 365,021 |
| Geoffrey M.D. Ling Director | Dec 19, 2025 | Award | +67,416 | – | – | 111,795 |
| Vincent LeVien Director | Nov 19, 2025 | Award | +3,699 | – | – | 3,699 |
| Geoffrey M.D. Ling Director | Nov 19, 2025 | Award | +44,379 | – | – | 111,795 |
| Peter Diamandis Director | Nov 19, 2025 | Award | +47,042 | – | – | 248,765 |
| Diane L. Parks Director | Nov 19, 2025 | Award | +61,539 | – | – | 365,021 |
| Robert J. Hariri Chief Executive Officer, Director | Apr 13, 2025 | Option exercise | +3,281 | – | – | 2,852,608 |
| Robert J. Hariri Chief Executive Officer, Director | Apr 13, 2025 | Tax withholding | −1,154 | $1.64 | $1.89K | 2,851,454 |
| Stephen Brigido Pres., Functional Regeneration | Apr 13, 2025 | Option exercise | +820 | – | – | 9,189 |
| Stephen Brigido Pres., Functional Regeneration | Apr 13, 2025 | Tax withholding | −268 | $1.64 | $440 | 8,921 |
| David C. Beers Chief Financial Officer | Apr 13, 2025 | Tax withholding | −360 | $1.64 | $590 | 18,201 |
| David C. Beers Chief Financial Officer | Apr 13, 2025 | Option exercise | +1,025 | – | – | 18,561 |
| John R. Haines Senior Exec Vice President | Apr 13, 2025 | Option exercise | +1,641 | – | – | 29,698 |
| John R. Haines Senior Exec Vice President | Apr 13, 2025 | Tax withholding | −577 | $1.64 | $946 | 29,121 |
| Robert J. Hariri Chief Executive Officer, Director | Apr 13, 2025 | Option exercise | +3,281 | – | – | 21,482 |
| Robert J. Hariri Chief Executive Officer, Director | Apr 13, 2025 | Tax withholding | −1,154 | $1.64 | $1.89K | 20,328 |
| Stephen Brigido Pres., Functional Regeneration | Feb 17, 2025 | Option exercise | +10,000 | – | – | 11,641 |
| Stephen Brigido Pres., Functional Regeneration | Feb 17, 2025 | Tax withholding | −3,272 | $2.14 | $7.00K | 8,369 |
| John R. Haines Senior Exec Vice President | Feb 17, 2025 | Option exercise | +20,000 | – | – | 35,092 |
| John R. Haines Senior Exec Vice President | Feb 17, 2025 | Tax withholding | −7,035 | $2.14 | $15.05K | 28,057 |
| David C. Beers Chief Financial Officer | Feb 17, 2025 | Option exercise | +12,500 | – | – | 21,932 |
| David C. Beers Chief Financial Officer | Feb 17, 2025 | Tax withholding | −4,396 | $2.14 | $9.41K | 17,536 |
| Berhad Genting 10% owner | Jan 24, 2025 | Option exercise | +652,981 | $2.07 | $1.35M | 6,335,630 |
| Berhad Genting 10% owner | Jan 24, 2025 | Option exercise | +535,274 | $2.07 | $1.11M | 5,682,649 |
| Peter Diamandis Director | Dec 19, 2024 | Award | +67,416 | – | – | 201,723 |
| Diane L. Parks Director | Dec 19, 2024 | Award | +67,416 | – | – | 303,482 |
| Dean C. Kehler Director | Dec 19, 2024 | Award | +67,416 | – | – | 303,482 |
| Richard J. Berman Director | Dec 19, 2024 | Award | +67,416 | – | – | 67,416 |
| Geoffrey M.D. Ling Director | Dec 19, 2024 | Award | +67,416 | – | – | 67,416 |
| Peter Diamandis Director | Dec 19, 2024 | Award | +67,416 | – | – | 1,374,482 |
| Kyle Fletcher See Remarks | Apr 13, 2024 | Tax withholding | −20 | $4.11 | $82 | 21,085 |
| Robert J. Hariri Chief Executive Officer | Apr 13, 2024 | Tax withholding | −1,154 | $4.11 | $4.74K | 2,855,889 |
| David C. Beers Chief Financial Officer | Apr 13, 2024 | Tax withholding | −360 | $4.11 | $1.48K | 23,983 |
| Stephen Brigido Pres, Functional Regeneration | Apr 13, 2024 | Tax withholding | −268 | $4.11 | $1.10K | 19,472 |
| John R. Haines See Remarks | Apr 13, 2024 | Tax withholding | −576 | $4.11 | $2.37K | 38,373 |
| Kyle Fletcher See Remarks | Mar 15, 2024 | Tax withholding | −617 | $5.68 | $3.50K | 21,105 |
| Kyle Fletcher See Remarks | Feb 17, 2024 | Tax withholding | −39,571 | $0.43 | $17.02K | 217,228 |
| David C. Beers Chief Financial Officer | Feb 17, 2024 | Tax withholding | −43,968 | $0.43 | $18.91K | 243,437 |
| John R. Haines See Remarks | Feb 17, 2024 | Tax withholding | −70,350 | $0.43 | $30.25K | 389,497 |
| Adrian Kilcoyne Chief Medical Officer | Feb 17, 2024 | Tax withholding | −52,762 | $0.43 | $22.69K | 1,122,238 |
| Stephen Brigido Pres, Functional Regeneration | Feb 17, 2024 | Tax withholding | −32,720 | $0.43 | $14.07K | 197,406 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.